FDA Approved: AMLODIPINE BESYLATE — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approves a supplemental application for AMLODIPINE BESYLATE from Aurobindo Pharma Limited under an ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Stable Angina
• Vasospastic Angina

Drugs mentioned

• Amlodipine besylate (amlodipine besylate)

Snippet

SUPPL AP for AMLODIPINE BESYLATE (AMLODIPINE BESYLATE)